Global Comprehensive Market Intelligence Report

Drug Developer's Intelligence Report

Neurology Drug Report

2014

Report covering World’s Largest Number of Active Neurology Drug Developers till May 2014

RELEASED - MAY 2014

480

Neurology Drug Developers

First time identifies and profiles 480 Active Neurology focused Drug Development companies.

Creates immense authentic knowledge-base on hundreds of proprietary technologies, M&A deals and partnering occurring in domain in last 10 years.

Neurology Drug Report 2014 (first Edition)

Covers all Aspects of Neurology Drug Development Intelligence

COMPANIES PROFILES * MOLECULES * INDICATIONS * TECHNOLOGIES * DEALS * FUNDING

largest coverage

providing intelligence at fingertips

1
Countries

Worldwide Extensive Coverage

1
Drug developers

Active 480 Neurology Drug Developer Profiles

1
Molecules

800+ Pipeline Molecules Profiles, Drug Target & Mechanism of Action.

1 +
Neurological Indications

With In-depth Market Analysis & Forecast of Individual Indication.

Perfect B2B Solution

intelligence supercharged

Unique first in class Intelligence Report

First Report to cover active 480 companies profiles including Clinical, Pre-Clinical & Discovery Companies, with 800+ active molecules in development for the treatment of various Neurological Disorders.

First Report to cover 19+ Neurological Disease full coverage, from latest pipeline updates & analysis to individual indication’s market size and sales forecast.

First Report to cover all LinkedIn & e-mail IDs of key decision makers (CXOs) in their respective company profiles, that further helps to scales up business development opportunities.

First Report to cover all details of companies covered in the form of 480 mini-reports and includes- past 5 years major business deals, funding, proprietary technologies and drug updates.

First innovative approach that helps to directly identify & link with the key decision maker.

Report is highly precise and designed keeping in mind to keep information intact, informative and self explanatory. Also, every piece of intelligence is cross validated.

Only facts, no guess work.

530+ Pages present complete picture of individual company’s pipeline, deals, partnering, funding etc. and outline individual company’s core strength and stand with respect to other drug developers.

Report documents all Neurology focused news/deals of every drug developers in past 10 years. Making it perfect tool for Decision Making and a big time saver too.

Compares Oranges with Oranges.

Only Active Neurology Drug Developing Companies, with no room to Diagnostic and Device companies; making data clear and impactful.

Most of the intelligence provider covers limited number of known companies, that too many of which have no links to the core title of the report. Also many renowned database too contains acquired/closed companies, thus driving final intelligence too tedious and time consuming exercise.

All our reports provides comprehensive intelligence, with largest active industry coverage and avoids investing money on other similar resources. Thus, saves lots of resources in terms of time and money, in identifying new partnering opportunities.

Each year, we publish very small number of comprehensive reports and are experts in identifying and tracking drug developers. We maintain our own database and track’s every individual company.

From last 10 years, our team exclusively providing marketing intelligence in field of Oncology and Neurology Drug Development.

intelligence supercharged

532 pages full of insights​

Other Reports in this Series

Neurology Drug Report 2014
Comprehensive Decision Making Intelligence derived from Active 480 Neurology Drug Developers.
Neurology Drug Report 2020
Comprehensive Decision Making Intelligence derived from Active 750 Neurology Drug Developers.
May 2014
Feburary 2020